Bruker Corporation to Present at Upcoming Investor Conferences
August 23 2024 - 3:01PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald
Herman, Executive Vice President & CFO will present on behalf
of the Company at the following investor conferences:
2024 Wells Fargo Healthcare Conference in Boston, MA
Wednesday, September 4, 2024, at 10:15 a.m. Eastern Time
Morgan Stanley 22nd Annual Global Healthcare Conference in
New York City Friday, September 6, 2024, at 10:00 a.m. Eastern
Time
Live audiovisual webcasts of the presentations will be available
on the Investor Relations section of the Company's website at
https://ir.bruker.com. Replays of the presentations will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the events and will be
available for 90 days following the presentations.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high-performance scientific
instruments and high-value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high-value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240823605948/en/
Joe Kostka Associate Director, Investor Relations Bruker
Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jan 2024 to Jan 2025